Jinyun Dong

2.6k total citations · 2 hit papers
65 papers, 2.1k citations indexed

About

Jinyun Dong is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Jinyun Dong has authored 65 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 28 papers in Organic Chemistry and 22 papers in Oncology. Recurrent topics in Jinyun Dong's work include Synthesis and biological activity (12 papers), Bioactive Compounds and Antitumor Agents (11 papers) and Cancer therapeutics and mechanisms (11 papers). Jinyun Dong is often cited by papers focused on Synthesis and biological activity (12 papers), Bioactive Compounds and Antitumor Agents (11 papers) and Cancer therapeutics and mechanisms (11 papers). Jinyun Dong collaborates with scholars based in China, United States and Hong Kong. Jinyun Dong's co-authors include Jiang‐Jiang Qin, Xiangdong Cheng, Shaoshun Li, Qijing Zhang, G. Huang, Weidong Zhang, Qingqing Meng, Zhiyuan Xu, Zengtao Wang and Weidong Zhang and has published in prestigious journals such as Nature Communications, Scientific Reports and ACS Applied Materials & Interfaces.

In The Last Decade

Jinyun Dong

63 papers receiving 2.0k citations

Hit Papers

PROTAC: An Effective Targ... 2021 2026 2022 2024 2021 2023 50 100 150 200

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Jinyun Dong 1.1k 733 479 209 190 65 2.1k
Linjiang Tong 1.5k 1.4× 604 0.8× 689 1.4× 99 0.5× 379 2.0× 99 2.3k
Daniel H. Albert 1.3k 1.2× 498 0.7× 582 1.2× 195 0.9× 180 0.9× 88 2.7k
Chuan Shih 1.4k 1.3× 687 0.9× 790 1.6× 112 0.5× 352 1.9× 81 2.9k
Shiow‐Lin Pan 2.2k 2.1× 634 0.9× 894 1.9× 261 1.2× 182 1.0× 148 3.8k
Yubo Zhou 1.7k 1.6× 469 0.6× 755 1.6× 162 0.8× 122 0.6× 171 2.8k
Hua Xiang 851 0.8× 389 0.5× 436 0.9× 438 2.1× 191 1.0× 133 2.0k
Gregory D. Vite 1.3k 1.2× 1.1k 1.5× 1.0k 2.2× 96 0.5× 206 1.1× 64 2.8k
Ute Hoch 858 0.8× 971 1.3× 244 0.5× 324 1.6× 268 1.4× 86 2.1k
Liguang Lou 1.9k 1.8× 1.5k 2.1× 697 1.5× 186 0.9× 613 3.2× 135 4.0k
Luoting Yu 1.6k 1.4× 476 0.6× 1.1k 2.4× 152 0.7× 157 0.8× 141 2.9k

Countries citing papers authored by Jinyun Dong

Since Specialization
Citations

This map shows the geographic impact of Jinyun Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinyun Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinyun Dong more than expected).

Fields of papers citing papers by Jinyun Dong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinyun Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinyun Dong. The network helps show where Jinyun Dong may publish in the future.

Co-authorship network of co-authors of Jinyun Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Jinyun Dong. A scholar is included among the top collaborators of Jinyun Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinyun Dong. Jinyun Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Li, Yulong, et al.. (2025). An updated review on the role of small molecules in mediating protein degradation. European Journal of Medicinal Chemistry. 287. 117370–117370. 4 indexed citations
3.
Dong, Jinyun, Yulong Li, Hui Liang, et al.. (2025). HSP70 Interactome‐Mediated Proteolysis Targeting Chimera (HSP70‐PROTAC) for Ferroptosis‐Driven Cancer Treatment. Advanced Science. 13(12). e13655–e13655. 1 indexed citations
4.
Li, Lu, et al.. (2025). Lactate drives senescence-resistant lineages in hepatocellular carcinoma via histone H2B lactylation of NDRG1. Cancer Letters. 616. 217567–217567. 8 indexed citations
5.
Dong, Jinyun, et al.. (2025). Hierarchical hazard-accident causal network analysis for offshore platform safety assessment. Process Safety and Environmental Protection. 200. 107372–107372.
6.
Dong, Jinyun, Maohua Cai, Haobin Li, et al.. (2024). Heat Shock Protein 90 Interactome-Mediated Proteolysis Targeting Chimera (HIM-PROTAC) Degrading Glutathione Peroxidase 4 to Trigger Ferroptosis. Journal of Medicinal Chemistry. 67(18). 16712–16736. 17 indexed citations
7.
Li, Yulong, et al.. (2024). ML162 derivatives incorporating a naphthoquinone unit as ferroptosis/apoptosis inducers: Design, synthesis, anti-cancer activity, and drug-resistance reversal evaluation. European Journal of Medicinal Chemistry. 270. 116387–116387. 14 indexed citations
8.
Li, Yulong, Jinyun Dong, & Jiang‐Jiang Qin. (2024). Small molecule inhibitors targeting heat shock protein 90: An updated review. European Journal of Medicinal Chemistry. 275. 116562–116562. 10 indexed citations
9.
Zhao, Jing, Yubo Ma, Li‐Bin Pan, et al.. (2023). Chebulagic acid suppresses gastric cancer by inhibiting the AURKA/β-catenin/Wnt pathway. Frontiers in Pharmacology. 14. 1143427–1143427. 6 indexed citations
10.
Li, Shengli, Yuan Li, Zhiyuan Xu, et al.. (2023). Integrative proteomic characterization of adenocarcinoma of esophagogastric junction. Nature Communications. 14(1). 778–778. 24 indexed citations
11.
Li, Yulong, Zheshen Li, Zhe‐Sheng Chen, et al.. (2023). Synthesis and evaluation of WK-X-34 derivatives as P-glycoprotein (P-gp/ABCB1) inhibitors for reversing multidrug resistance. RSC Medicinal Chemistry. 15(2). 506–518. 12 indexed citations
12.
Hu, Can, Jingli Xu, Yuan Li, et al.. (2023). Polyphyllin B Suppresses Gastric Tumor Growth by Modulating Iron Metabolism and Inducing Ferroptosis. International Journal of Biological Sciences. 19(4). 1063–1079. 36 indexed citations
13.
Dong, Jinyun, Zi Hui, Carmen Garrido, et al.. (2022). An updated patent review of protein arginine N-methyltransferase inhibitors (2019–2022). Expert Opinion on Therapeutic Patents. 32(12). 1185–1205. 16 indexed citations
14.
Li, Haobin, Jinyun Dong, Maohua Cai, et al.. (2021). Protein degradation technology: a strategic paradigm shift in drug discovery. Journal of Hematology & Oncology. 14(1). 138–138. 60 indexed citations
15.
Dong, Jinyun, Xiangdong Cheng, Weidong Zhang, & Jiang‐Jiang Qin. (2021). Recent Update on Development of Small-Molecule STAT3 Inhibitors for Cancer Therapy: From Phosphorylation Inhibition to Protein Degradation. Journal of Medicinal Chemistry. 64(13). 8884–8915. 157 indexed citations
16.
Huang, G., Wen Zhou, Jinyun Dong, et al.. (2017). 6-Substituted 1,4-naphthoquinone oxime derivatives (I): synthesis and evaluation of their cytotoxic activity. Monatshefte für Chemie - Chemical Monthly. 148(6). 1011–1023. 12 indexed citations
17.
Shan, Yuanyuan, Jinyun Dong, Xiaoyan Pan, et al.. (2015). Expanding the structural diversity of Bcr-Abl inhibitors: Dibenzoylpiperazin incorporated with 1H-indazol-3-amine. European Journal of Medicinal Chemistry. 104. 139–147. 22 indexed citations
18.
Dong, Jinyun, Xiaoyan Pan, Jinfeng Wang, et al.. (2015). Synthesis and biological evaluation of novel aromatic-heterocyclic biphenyls as potent anti-leukemia agents. European Journal of Medicinal Chemistry. 101. 780–789. 7 indexed citations
19.
Han, Sheng, Jinyun Dong, Y Liu, et al.. (2014). Tumour-infiltrating CD4+ and CD8+ lymphocytes as predictors of clinical outcome in glioma. British Journal of Cancer. 110(10). 2560–2568. 274 indexed citations
20.
Lu, Wen, Fang Wang, Tao Zhang, et al.. (2014). Search for novel histone deacetylase inhibitors. Part II: Design and synthesis of novel isoferulic acid derivatives. Bioorganic & Medicinal Chemistry. 22(9). 2707–2713. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026